ARHGAP26 (GRAF): A Potential Drug Target Or Biomarker (G23092)

Target Name: ARHGAP26

NCBI ID: G23092

ARHGAP26

ARHGAP26 (GRAF): A Potential Drug Target Or Biomarker

ARHGAP26 (GRAF) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling.

Members of the GPCR family usually consist of an 伪-helix, a 尾-sheet, and a 纬-chain. These chains combine with each other through hydrogen bonds and other non-covalent interactions to form a complex three-dimensional structure. This structure enables GPCR members to interact with ligand molecules and transmit signals into the cell interior.

ARHGAP26 (GRAF) is a member of the GPCR family, which plays important biological functions in organisms. In certain diseases, ARHGAP26 (GRAF) may be a potential drug target or biomarker.

The function of ARHGAP26 (GRAF) is mainly reflected in its signal transduction pathway. In the signal transduction pathway, ARHGAP26 (GRAF) binds to GPCR ligands, thereby triggering a series of signal transduction reactions. These signal transduction reactions can lead to the production or degradation of a series of biochemical substances in cells, such as protein phosphorylation, phosphorylation, protein modification, etc.

The role of ARHGAP26 (GRAF) in various diseases is also reflected in its relationship with tumors. In tumors, the expression level of ARHGAP26 (GRAF) often changes, thereby affecting the growth and survival of tumor cells. Some studies have shown that the expression level of ARHGAP26 (GRAF) is positively correlated with tumor invasiveness and metastasis. Therefore, ARHGAP26 (GRAF) may be an important biomarker for detecting tumor invasiveness and metastasis.

ARHGAP26 (GRAF) may also be a potential drug target. In some cases, overexpression of ARHGAP26 (GRAF) may be associated with the occurrence of certain diseases. For example, overexpression of ARHGAP26 (GRAF) in Alzheimer's disease has been shown to be associated with progression of the disease and cognitive decline. Therefore, ARHGAP26 (GRAF) may be a potential drug target for the treatment of diseases such as Alzheimer's disease.

ARHGAP26 (GRAF) is an important protein that plays important biological functions in organisms. In certain diseases, ARHGAP26 (GRAF) may be a potential drug target or biomarker. Future research will continue to further study the role of ARHGAP26 (GRAF) in diseases and provide new ideas for the treatment of these diseases.

Protein Name: Rho GTPase Activating Protein 26

Functions: GTPase-activating protein for RHOA and CDC42

The "ARHGAP26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARHGAP26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets